The estimated Net Worth of Bakker Juliet Tammenoms is at least $270 Million dollars as of 20 October 2020. Ms. Tammenoms owns over 233,333 units of Axonics Inc stock worth over $269,331,632 and over the last 8 years she sold AXNX stock worth over $494,581. In addition, she makes $572,081 as Independent Director at Axonics Inc.
Sign up
Ms. Bakker AXNX stock SEC Form 4 insiders trading
Juliet has made over 5 trades of the Axonics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently she bought 233,333 units of AXNX stock worth $4,199,994 on 20 October 2020.
The largest trade she's ever made was buying 533,333 units of Axonics Inc stock on 2 November 2018 worth over $7,999,995. On average, Juliet trades about 46,329 units every 57 days since 2016. As of 20 October 2020 she still owns at least 3,918,691 units of Axonics Inc stock.
You can see the complete history of Ms. Tammenoms stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Juliet Tammenoms Bakker biography
Juliet Tammenoms Bakker serves as Independent Director of the Company. Juliet Tammenoms Bakker has served as a member of our Board since March 2018 and as a member of our compensation committee and the Chair of our nominating and corporate governance committee since October 2018. Since January 2007, Ms. Tammenoms Bakker has served as a Managing Director of Longitude Capital Management Co., LLC, a healthcare venture capital firm. Ms. Tammenoms Bakker holds a B.Sc. from the College of Agriculture and Life Sciences at Cornell University and a M.P.A from the John F. Kennedy School of Government at Harvard University.
What is the salary of Juliet Bakker?
As the Independent Director of Axonics Inc, the total compensation of Juliet Bakker at Axonics Inc is $572,081. There are 8 executives at Axonics Inc getting paid more, with Raymond Cohen having the highest compensation of $6,147,640.
How old is Juliet Bakker?
Juliet Bakker is 58, she's been the Independent Director of Axonics Inc since 2018. There are 7 older and 13 younger executives at Axonics Inc. The oldest executive at Axonics Inc is Nancy Snyderman, 68, who is the Independent Director.
What's Juliet Bakker's mailing address?
Bakker's mailing address filed with the SEC is C/O EARGO, INC., 1600 TECHNOLOGY DRIVE, 6TH FLOOR, MENLO PARK, CA, 95110.
Insiders trading at Axonics Inc
Over the last 6 years, insiders at Axonics Inc have traded over $108,010,643 worth of Axonics Inc stock and bought 4,672,163 units worth $70,180,620 . The most active insiders traders include Asset Management, Lp Chen B..., Shahzad Malik und Geoff Pardo. On average, Axonics Inc executives and independent directors trade stock every 15 days with the average trade being worth of $4,280,711. The most recent stock trade was executed by Raymond W Cohen on 24 July 2024, trading 103,896 units of AXNX stock currently worth $2,383,374.
What does Axonics Inc do?
axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.
What does Axonics Inc's logo look like?
Complete history of Ms. Tammenoms stock trades at Aimmune Therapeutics Inc, Corcept Therapeutics Inc, Axonics Inc, Venus Concept und Eargo
Axonics Inc executives and stock owners
Axonics Inc executives and other stock owners filed with the SEC include:
-
Raymond Cohen,
Chief Executive Officer, Director -
Dan Dearen,
President, Chief Financial Officer -
Rinda Sama,
Chief Operating Officer -
Raymond W. Cohen,
CEO & Director -
Danny L. Dearen,
Pres & CFO -
Dr. Karen L. Noblett M.D., M.A.S.,
Chief Medical Officer -
Rinda K. Sama,
Chief Operating Officer -
Robert McNamara,
Independent Director -
Juliet Tammenoms Bakker,
Independent Director -
Alfred J. Ford Jr.,
Chief Commercial Officer -
Erik Amble,
Independent Director -
Michael Carrel,
Independent Chairman of the Board -
Jane Kiernan,
Independent Director -
Nancy Snyderman,
Independent Director -
Karen Noblett,
Chief Medical Officer -
Prabodh Mathur,
Chief Product Development Officer -
Alfred Ford,
Chief Commercial Officer -
John Woock,
Chief Marketing Officer -
Dr. Karen L. Noblett M.A.S., M.D.,
Chief Medical Officer -
Michael V. Williamson Esq., J.D.,
Sr. VP, Gen. & IP Counsel -
Michael V. Williamson,
Sr. VP, Gen. & IP Counsel -
Dr. John Woock Ph.D.,
Exec. VP, Chief Marketing & Strategy Officer -
Aaron Pettit,
Gen. Counsel & Chief Compliance Officer -
Neil Bhalodkar,
VP of Investor Relations -
Guangqiang Jiang Ph.D.,
Chief Technology Officer -
Esteban Lopez,
-
John George Petrovich,
Director -
Shahzad Malik,
Director -
Life Sciences Llp Advent Li...,
-
Partners Bio Discovery 4 Fc...,
-
E. Mann Foundation For Scie...,
-
Capital Partners Iii, Llcen...,
-
Innovation V Ltd Neo Med In...,
-
Healthcare Holding B.V.Gild...,
-
Asset Management, Lp Chen B...,
-
Michael V. Williamson,
SVP, General Counsel -
Guangqiang Jiang,
Chief Technology Officer -
Zhong Zac & Cloud Holdings ...,
-
Raphael Wisniewski,
-
Robert E Mcnamara,
-
Geoff Pardo,
-
David M Demski,
-
Kari Leigh Keese,
Chief Financial Officer